Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities:
Net loss	$ (115,543)	$ (3,755)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on investment held in Trust Account	(3,247)
Changes in current assets and current liabilities:
Deferred offering costs	207,325	(138,017)
Prepaid assets	(226,723)
Accounts payable and accrued expense	223,905
State franchise tax accrual	7,225
Due to related parties	3,548
Net cash provided by/(used in) operating activities	96,490	(141,772)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(139,380,000)
Net cash used in investing activities	(139,380,000)
Cash Flows from Financing Activities:
Proceeds from issuance of 150,000 representative shares	15
Proceeds from share issuance to Underwriter and collection of subscription receivable from initial stockholder		5,020
Proceeds from initial public offering, net of underwriters’ discount	135,240,000
Proceeds from private placement	5,390,000
Proceeds from Sponsor loan	150,000	150,000
Repayment of Sponsor loan	(300,000)
Payments of offering costs	(532,623)
Net cash provided by financing activities	139,947,392	155,020
Net Increase in Cash	663,882	13,248
Cash - Beginning	13,248
Cash - Ending	677,130	13,248
Supplemental Disclosure of Non-cash Financing Activities:
Increase in deferred offering costs for stock issued to Underwriter		248
Increase in account payable for deferred offering costs		$ 69,060
Sponsor shares surrendered as part of downsizing	(86)
1 for 1.2 stock dividend as part of upsizing	64
Shares surrendered by Underwriter for no consideration	(4)
Initial value of common stock subject to possible redemption	135,094,307
Change in value of common stock subject to possible redemption	$ (110,948)